Low Jam-a expression was correlated with poor prognosis in gastric cancer, pancreatic cancer and breast cancer and was also positively associated with the sensitivity of multiple myeloma cells to chemotherapeutic drugs [21–23]. Here, F11R is linked to breast cancer.